Efficacy of peritoneal dialysis of tolbutamide in rats under conditions of the plasma unbound fraction being increased

Takashi Makita, Tetsuya Aiba, Yuki Izuwa, Yukiko Komori, Hiromu Kawasaki, Yuji Kurosaki

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Peritoneal dialysis of a highly protein-bound compound, tolbutamide, was examined in rats to clarify whether the efficacy of the peritoneal dialysis of such compounds increases proportionally as their unbound fractions increase. As expected, it was shown that the tolbutamide concentration of the peritoneal dialysate rose as the unbound fraction of tolbutamide increased. However, the efficacy of peritoneal dialysis of tolbutamide was proportionally elevated only when the unbound fraction was slightly increased by sulfamethoxazole treatment. When the unbound fraction of tolbutamide was increased 7.8 times by sulfadimethoxine treatment, the dialysis efficacy was increased to only 58% of that expected. This discrepancy between the observed and expected values regarding dialysis efficacy was more marked when experiments were performed in rats with experimentally induced acute renal failure. Pharmacokinetic analysis indicated that the intrinsic dialysis clearance of tolbutamide decreased when its unbound fraction was greatly increased. These findings suggest that peritoneal dialysis may be mediated not only by passive diffusion, but also by concentration-dependent processes. The efficacy of the peritoneal dialysis of therapeutic compounds may be overestimated if the estimation is based only on their unbound fraction measured under control conditions.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalBiopharmaceutics and Drug Disposition
Volume30
Issue number1
DOIs
Publication statusPublished - 2009

Fingerprint

Tolbutamide
Peritoneal Dialysis
Dialysis
Sulfadimethoxine
Sulfamethoxazole
Dialysis Solutions
Acute Kidney Injury
Pharmacokinetics
Therapeutics
Proteins

Keywords

  • Acute renal failure
  • Peritoneal dialysis
  • Protein binding
  • Sulfonamides
  • Tolbutamide

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmaceutical Science
  • Pharmacology

Cite this

Efficacy of peritoneal dialysis of tolbutamide in rats under conditions of the plasma unbound fraction being increased. / Makita, Takashi; Aiba, Tetsuya; Izuwa, Yuki; Komori, Yukiko; Kawasaki, Hiromu; Kurosaki, Yuji.

In: Biopharmaceutics and Drug Disposition, Vol. 30, No. 1, 2009, p. 1-8.

Research output: Contribution to journalArticle

@article{9da4630f3bdc4313afa94175eae0cbdf,
title = "Efficacy of peritoneal dialysis of tolbutamide in rats under conditions of the plasma unbound fraction being increased",
abstract = "Peritoneal dialysis of a highly protein-bound compound, tolbutamide, was examined in rats to clarify whether the efficacy of the peritoneal dialysis of such compounds increases proportionally as their unbound fractions increase. As expected, it was shown that the tolbutamide concentration of the peritoneal dialysate rose as the unbound fraction of tolbutamide increased. However, the efficacy of peritoneal dialysis of tolbutamide was proportionally elevated only when the unbound fraction was slightly increased by sulfamethoxazole treatment. When the unbound fraction of tolbutamide was increased 7.8 times by sulfadimethoxine treatment, the dialysis efficacy was increased to only 58{\%} of that expected. This discrepancy between the observed and expected values regarding dialysis efficacy was more marked when experiments were performed in rats with experimentally induced acute renal failure. Pharmacokinetic analysis indicated that the intrinsic dialysis clearance of tolbutamide decreased when its unbound fraction was greatly increased. These findings suggest that peritoneal dialysis may be mediated not only by passive diffusion, but also by concentration-dependent processes. The efficacy of the peritoneal dialysis of therapeutic compounds may be overestimated if the estimation is based only on their unbound fraction measured under control conditions.",
keywords = "Acute renal failure, Peritoneal dialysis, Protein binding, Sulfonamides, Tolbutamide",
author = "Takashi Makita and Tetsuya Aiba and Yuki Izuwa and Yukiko Komori and Hiromu Kawasaki and Yuji Kurosaki",
year = "2009",
doi = "10.1002/bdd.640",
language = "English",
volume = "30",
pages = "1--8",
journal = "Biopharmaceutics and Drug Disposition",
issn = "0142-2782",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Efficacy of peritoneal dialysis of tolbutamide in rats under conditions of the plasma unbound fraction being increased

AU - Makita, Takashi

AU - Aiba, Tetsuya

AU - Izuwa, Yuki

AU - Komori, Yukiko

AU - Kawasaki, Hiromu

AU - Kurosaki, Yuji

PY - 2009

Y1 - 2009

N2 - Peritoneal dialysis of a highly protein-bound compound, tolbutamide, was examined in rats to clarify whether the efficacy of the peritoneal dialysis of such compounds increases proportionally as their unbound fractions increase. As expected, it was shown that the tolbutamide concentration of the peritoneal dialysate rose as the unbound fraction of tolbutamide increased. However, the efficacy of peritoneal dialysis of tolbutamide was proportionally elevated only when the unbound fraction was slightly increased by sulfamethoxazole treatment. When the unbound fraction of tolbutamide was increased 7.8 times by sulfadimethoxine treatment, the dialysis efficacy was increased to only 58% of that expected. This discrepancy between the observed and expected values regarding dialysis efficacy was more marked when experiments were performed in rats with experimentally induced acute renal failure. Pharmacokinetic analysis indicated that the intrinsic dialysis clearance of tolbutamide decreased when its unbound fraction was greatly increased. These findings suggest that peritoneal dialysis may be mediated not only by passive diffusion, but also by concentration-dependent processes. The efficacy of the peritoneal dialysis of therapeutic compounds may be overestimated if the estimation is based only on their unbound fraction measured under control conditions.

AB - Peritoneal dialysis of a highly protein-bound compound, tolbutamide, was examined in rats to clarify whether the efficacy of the peritoneal dialysis of such compounds increases proportionally as their unbound fractions increase. As expected, it was shown that the tolbutamide concentration of the peritoneal dialysate rose as the unbound fraction of tolbutamide increased. However, the efficacy of peritoneal dialysis of tolbutamide was proportionally elevated only when the unbound fraction was slightly increased by sulfamethoxazole treatment. When the unbound fraction of tolbutamide was increased 7.8 times by sulfadimethoxine treatment, the dialysis efficacy was increased to only 58% of that expected. This discrepancy between the observed and expected values regarding dialysis efficacy was more marked when experiments were performed in rats with experimentally induced acute renal failure. Pharmacokinetic analysis indicated that the intrinsic dialysis clearance of tolbutamide decreased when its unbound fraction was greatly increased. These findings suggest that peritoneal dialysis may be mediated not only by passive diffusion, but also by concentration-dependent processes. The efficacy of the peritoneal dialysis of therapeutic compounds may be overestimated if the estimation is based only on their unbound fraction measured under control conditions.

KW - Acute renal failure

KW - Peritoneal dialysis

KW - Protein binding

KW - Sulfonamides

KW - Tolbutamide

UR - http://www.scopus.com/inward/record.url?scp=59949090876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59949090876&partnerID=8YFLogxK

U2 - 10.1002/bdd.640

DO - 10.1002/bdd.640

M3 - Article

C2 - 19148953

AN - SCOPUS:59949090876

VL - 30

SP - 1

EP - 8

JO - Biopharmaceutics and Drug Disposition

JF - Biopharmaceutics and Drug Disposition

SN - 0142-2782

IS - 1

ER -